In 3/5 CD34-positive AML cases that we analyzed a very small amount of ALDHbright progenitors contained FLT3-ITD and/or NPM1 mutations and might therefore be leukemic (Table S3B, Figure 5B). Here, FLT3 is linked to acute myeloid leukemia.